The Vancouver-based cannabis company said it will distribute, through its wholly-owned subsidiary Satipharm Ltd, GenCannaâ€™s products in certain regulated markets in the US, Europe, and elsewhere globally.
The products will be sold under the Dream Water, Satipharm, and LivRelief brands for an initial term of two years.
In addition, Winchester, Kentucky-based GenCanna will support Harvest One in the research, development, and formulation of both existing and new CBD-infused products.
Harvest One said the agreement with GenCanna ensures the consistent supply of premium quality hemp-derived CBD for infusion in its existing products and further product innovation.
“Working with world-class partners like GenCanna to supply premium quality, traceable, consistent ingredients, all from GMP-certified facilities, is critical to our core strategy at Harvest One to only offer consumers best-in-class premium products, with consistent and predictable effects, in delivery formats they have come to understand and demand,” said Harvest One CEO Grant Froese.
The company serves as an umbrella over three wholly-owned subsidiaries: United Greeneries, which is a licensed producer; Satipharm, which develops cannabis-based health products; and Dream Water, which offers consumer sleep aids.
Harvest One’s stock recently traded up 3.45% to C$0.60 a share in Toronto and 1.7% to US$0.47 a share on the OTC Markets.
Contact the author: [emailÂ protected]
Follow him on Twitter @PatrickMGraham